Allergy Therapeutics PLC Stock
Price
Target price
€0.085
€0.085
8.330%
0.0065
8.330%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Allergy Therapeutics PLC Stock
Allergy Therapeutics PLC dominated the market today, gaining €0.007 (8.330%).
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
B****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | 8.330% | 16.552% | 17.361% | 59.434% | 23.358% | -61.591% | - |
| Beximco Pharmaceuticals Ltd. GDR | -2.380% | -0.485% | -0.485% | -4.206% | -0.966% | -47.436% | 12.637% |
| SELLAS Life Sciences Group Inc | 5.000% | 18.519% | 30.044% | 63.504% | 90.436% | -15.232% | -27.829% |
| Eledon Pharmaceuticals Inc. | -3.450% | -3.448% | -12.500% | -1.754% | -45.098% | -1.754% | -65.432% |
News
3 High-Yielding Dividend Stocks to Buy for the Long Haul
The average stock on the S&P 500 yields just 1.3%. That's a modest return on your money, but that's only the average. There are many dividend stocks that pay you much more than that. While you don't
This Dividend Stock Is Up 4 Times More Than the S&P 500 in the Past Year. Here's Why I'm Loading Up On It.
The S&P 500 (SNPINDEX: ^GSPC), the stock market's most widely followed index, has delivered slightly better than average returns over the past 12 months, rising by around 12%. However, the market's
AT&T: Is This Telecom Giant a Buy or a Bye for Your Portfolio?
[content-module:CompanyOverview|NYSE:T]
Investor focus on AT&T (NYSE: T) is starting to sharpen, with the company’s stock price making a healthy upward move of nearly 50% over the past year as of
